Clinical Trial Update: A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

View source ↗

Summary

A real-world study evaluating how current clinical treatment guidelines guide the use of sacubitril/valsartan in patients with heart failure with reduced ejecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure With Reduced Ejection Fraction | Status: ACTIVE_NOT_RECRUITING